Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Hope S. Rugo
Based on 153 articles published since 2008
||||
Expertise Level
The expertise of Hope S. Rugo ranks in the
  • Top 0.00078%
  • ... of 255,217 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 153 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Rugo, H S   ·   Rugo, H   ·   Rugo, Hope S   ·   Rugo, Hope
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2018
  • a Division of Hematology and Oncology , Massachusetts General Hospital , Boston , MA , USA. · b Division of Hematology and Oncology , University of California San Francisco, Helen Diller Family Comprehensive Cancer Center , San Francisco , CA , USA. · Pubmed 29192520
  • Global Product Development, Pfizer Inc., San Diego. · Pfizer Inc. · Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Obstetrics and Gynecology, Right of the Isar Hospital, Technical University of Munich, Munich, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 29360661
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University, Cancer Hospital & Institute, Beijing, 100142, China. · Pubmed 29282695
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Wake Forest University Baptist Medical Center, Medical Center Blvd, Fl 3, Winston Salem, NC, 27157, USA. · Medical Device Consultants Ridgewood, LLC, 99 Glenwood Rd, Ridgewood, NJ, 07450, USA. · Pubmed 28275922
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · University of Chicago, Chicago, Illinois, USA. · NorthShore University Health System, Evanston, Illinois, USA. · State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing, China. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/ Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Rochester, Minnesota, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/ Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California-San Francisco, San Francisco, California, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, 20 N Pine Street, Room 513, Baltimore, Maryland, 21201, USA. · Pubmed 28620884
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Valley Medical Oncology Consultants, Stanford Health Care, 2505 Hospital Drive, Mountain View, CA, 94040, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Pubmed 28577080
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · University of California San Francisco School of Medicine, Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA. · Pubmed 28503722
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Biocon Research Limited, Bangalore, India3Now with Mylan Inc, Canonsburg, Pennsylvania. · Department of Haematology, Oncology, and Stem Cell Transplantation, University Medical Centre Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Quiron-Dexeus, Barcelona, Spain. · Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. · Mylan Inc, Canonsburg, Pennsylvania. · Biocon Research Limited, Bangalore, India. · City Clinical Oncology Dispensary, Saint Petersburg, Russia. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Regional Clinical Oncological Center, Kazan, Russia. · Institute of Clinical Oncology, Tbilisi, Georgia. · St Luke's Medical Center Global City, Taguig City, Philippines. · Cardinal Santos Medical Center, Manila, Philippines. · Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia. · Siriraj Hospital, Bangkok, Thailand. · Sumy State University, Sumy, Ukraine. · King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. · City Cancer Center, Vijayawada, India. · Curie Manavata Cancer Centre, Nasik, India. · Instituto Clinico Oncologico del Sur, Temuco, Chile. · Pubmed 27918780
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Samuel Merritt University, Oakland, California. · Pubmed 27832260
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 28949948
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, 94115, USA. Electronic address: · Helsinn Healthcare SA, 6912, Pazzallo, Lugano, Switzerland. · IMO Clinique de Genolier, CH-1272, Genolier, Vaud, Switzerland. · Pubmed 28285236
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 29200414
2016
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27185850
  • School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, Connecticut. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, New York. · Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York. · School of Dentistry, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington. · New York University College of Dentistry, New York, New York. · Penn State Hershey Medical Center, Hershey, Pennsylvania. · Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California. · School of Dentistry and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. · Pubmed 27334013
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 26507507
  • Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. · Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26303211
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Kenilworth, NJ, USA. · Merck Research Laboratories, North Wales, PA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Sanfrancisco, CA, USA. · Pubmed 26875185
  • Department of Cell and Tissue Biology, University of California, San Francisco (UCSF), San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. · Department of Surgery, University of California, San Francisco, San Francisco, California, USA. · Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA. · Department of Anatomy, University of California, San Francisco, San Francisco, California, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. · Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. · Department of Medicine, University of California, San Francisco, San Francisco, California, USA. · Pubmed 27775705
  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. · Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA. · Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. · Department of Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 27224917
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. Electronic address: · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 26874902
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27379943
2015
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • University of Alabama at Birmingham, Birmingham, Alabama. · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · University of Alabama at Birmingham, Birmingham, Alabama. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Georgetown University Hospital, Washington, District of Columbia. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The University of Chicago, Chicago, Illinois. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Michigan, Ann Arbor, Michigan. · Baylor College of Medicine, Houston, Texas. · University of North Carolina, Chapel Hill, North Carolina. · Mayo Clinic College of Medicine, Rochester, Minnesota. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · Pubmed 25779953
  • Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 26520840
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA, 94115, United States of America. · Siemens Healthcare Diagnostics, Elkhart, IN, 46516, United States of America. · Pubmed 26496203
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • University of Pennsylvania, Philadelphia, Pennsylvania. · University of Minnesota, Minneapolis, Minnesota. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Loyola University Medical Center, Maywood, Illinois. · Buck Institute for Research on Aging, Novato, California. · Mayo Clinic, Rochester, Minnesota. · University of California, San Francisco, San Francisco, California. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Oregon Health and Science University, Portland, Oregon. · Inova Fairfax Hospital Cancer Center, Fairfax, Virginia. · University of Colorado Denver, Denver, Colorado. · University of Alabama at Birmingham, Birmingham, Alabama. · University of Texas Southwestern, Dallas, Texas. · Georgetown University Medical Center, Washington, DC. · Swedish Cancer Institute, Seattle, Washington. · University of Washington, Seattle, Washington. · Emory University, Atlanta, Georgia. · H. Lee Moffitt Cancer Center, Tampa, Florida. · University of Chicago, Chicago, Illinois. · QuantumLeap Healthcare Collaborative, San Francisco, California. · University of California, San Diego, San Diego, California. · Gemini Group Ann Arbor, Michigan. · George Mason University, Fairfax County, Virginia. · University of Southern California, Los Angeles, California. · University of Arizona Cancer Center, Tucson, Arizona. · University of California, San Francisco, San Francisco, California. · Pubmed 25712686
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Baylor University College of Medicine, Houston, Texas. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Duke University Medical Center, Durham, North Carolina. · Georgetown University, Washington, District of Columbia. · Laura & Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25524311
  • Augmentium Pharma Consulting Inc, Toronto, Ontario, Canada. Electronic address: · Sylvester Comprehensive Care Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida. · Eisai Inc, Woodcliff Lake, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25433768
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, California. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25351747
  • Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address: · Department of Radiation Medicine and Applied Sciences, University of California San Diego Moores Cancer Center, San Diego, CA. · Athena Breast Health Network, San Francisco, CA. · Department of Medicine (Hematology/Oncology), University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Department of Surgical Oncology, Duke University, Durham, NC. · Department of Surgical Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. · Department of Radiation Oncology, University of California Irvine, Orange, CA. · Department of Radiation Oncology, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica, Santa Monica, CA. · Department of Radiation Oncology, University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Pubmed 25245425
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • From the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Pubmed 25006724
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 250 25th Avenue N, Ste 100 Nashville, TN 37203, USA. · Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. · University of Pittsburgh Cancer Institute, 200 Lothrop Street, Pittsburgh, PA 15213, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon, NH 03756, USA. · AdvancedBC.org 250 West 82 Street, #42, New York, NY 10024, USA. · Statistical Innovations Inc, 375 Concord Avenue, Belmont, MA 02478, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. · 1] EpiSource, LLC, 53 Fenwick Road, Waban, MA 02468, USA [2] Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA. · Pubmed 24743708
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. · Pubmed 24615500
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA · Institut Multidisciplinaire D'Oncologie, Genolier, Switzerland. · Pubmed 25085504
2013
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-0875, USA. · Pubmed 23649189
  • University of California San Francisco, San Francisco, California. · Pubmed 24892840
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 24637554
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143-1710, USA, · Pubmed 24062208
2012
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., 2nd Floor, Box 1710, B-608, San Francisco, CA 94143, USA. · Pubmed 22198412
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, USA. · Pubmed 22393793
2011
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Ave, Second Floor, Box 1710, San Francisco, CA 94115, USA. · Pubmed 21555686
  • UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, CA, USA. · Pubmed 22362269
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 22355830
2010
  • University of California, San Francisco, CA 94115 , USA. · Pubmed 20705561
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 94115, USA. · Pubmed 20051811
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2016
  • Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center; Barbara Fowble, University of California San Francisco, San Francisco; Rita S. Mehta, University of California Irvine, Orange, CA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA; Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH; Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI; Hannah Klein Connolly, Patient Representative, Edina, MN; Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex; Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom; James N. Ingle, Mayo Clinic, Rochester, MN; Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL; Larissa A. Korde, University of Washington, Seattle, WA; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA. · Pubmed 27217461
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California; Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.); U.S. Oncology Research, The Woodlands, TX (S.J.); Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); British Columbia Cancer Agency, Vancouver, Canada (K.G.); Brustzentrum der Universität München (LMU), Munich, Germany (N.H.); State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.); All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.); M.D. Anderson Cancer Center, University of Texas, Houston (S.M.); and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Department of Medicine, University of California, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA, · Pubmed 26208485
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
2014
  • Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25349301
  • A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, and Mark M. Moasser, Helen Diller Family Comprehensive Cancer Center; A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, Karen Ordovas, and Mark M. Moasser, University of California San Francisco, San Francisco, CA; and Kevin M. Koch, GlaxoSmithKline, Research Triangle Park, NC. · Pubmed 24711549
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • 1233 Arguello Blvd, San Francisco, CA 94122, USA. · Pubmed 24142513
2013
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero Street, Box 1710, San Francisco, CA 94143-1710, USA. · Pubmed 23143215
  • Authors' Affiliations: Breast Cancer Medicine Service, Departments of Pathology, Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York; Dana-Farber Cancer Institute; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Rochester, Minnesota; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia; University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham, North Carolina; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California; University of Alabama at Birmingham, Birmingham, Alabama; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Pubmed 23965901
  • Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 23135909
2012
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 2nd floor, San Francisco, CA 94115, USA. · Pubmed 23148612
  • School of Medicine, University of California, San Francisco, 1106 Stanyan St., San Francisco, CA 94117, USA. · Pubmed 22798157
  • Department of Anatomy, University of California, San Francisco, CA 94143, USA. · Pubmed 22728437
  • Breast Care Center, University of California at San Francisco, 1600 Divisadero St, 2nd Floor, Box 1710, San Francisco, CA 94115, USA. · Pubmed 22649152
  • School of Nursing, University of California, San Francisco, California 94143-0610, USA. · Pubmed 22515947
  • Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 22207277
  • University of California San Francisco, 1600 Divisadero Street, Box 1710, San Francisco, CA 94115, USA. · Pubmed 22198468
  • Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 21825174
2011
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 22142661
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 21480257
  • Division of Hematology and Oncology, University of California, San Francisco, 1600 Divisadero, Rm A719 Box 1711, San Francisco, CA 94143, USA. · Pubmed 21559012
  • Department of Pathology, University of California, San Francisco, USA. · Pubmed 22039576
2010
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Pubmed 20805062
  • Department of Medicine, University of California San Francisco, 94115, USA. · Pubmed 20602189
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 20175700
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 20164688
2009
  • University of California San Francisco, San Francisco, CA, US. · Pubmed 19593514
  • University of California, San Francisco, CA, United States. · Pubmed 19850438
Probable:    Washington University   Contact    
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
2015
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
Probable:    University of San Francisco      
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 153 total) written by Hope S. Rugo about Breast Neoplasms:

  • Emerging data on improving response to hormone therapy: the role of novel targeted agents. 2018
  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. 2018
  • Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Strategies and Progress of Endocrine Therapy for Patients with Metastatic Breast Cancer. 2017
  • Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. 2017
  • A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. 2017
  • Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance). 2017
  • Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657). 2017
Show List of Full Article Records
Google Searches

Learn more about Hope S. Rugo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Washington University
University of San Francisco
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of California San Francisco
2018
  • a Division of Hematology and Oncology , Massachusetts General Hospital , Boston , MA , USA. · b Division of Hematology and Oncology , University of California San Francisco, Helen Diller Family Comprehensive Cancer Center , San Francisco , CA , USA. · Pubmed 29192520
  • Global Product Development, Pfizer Inc., San Diego. · Pfizer Inc. · Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Obstetrics and Gynecology, Right of the Isar Hospital, Technical University of Munich, Munich, Germany. · Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Pubmed 29360661
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University, Cancer Hospital & Institute, Beijing, 100142, China. · Pubmed 29282695
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, 1600 Divisadero St, San Francisco, CA, 94115, USA. · Wake Forest University Baptist Medical Center, Medical Center Blvd, Fl 3, Winston Salem, NC, 27157, USA. · Medical Device Consultants Ridgewood, LLC, 99 Glenwood Rd, Ridgewood, NJ, 07450, USA. · Pubmed 28275922
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · University of Chicago, Chicago, Illinois, USA. · NorthShore University Health System, Evanston, Illinois, USA. · State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing, China. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/ Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Rochester, Minnesota, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/ Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California-San Francisco, San Francisco, California, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, 20 N Pine Street, Room 513, Baltimore, Maryland, 21201, USA. · Pubmed 28620884
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Valley Medical Oncology Consultants, Stanford Health Care, 2505 Hospital Drive, Mountain View, CA, 94040, USA. · University of California, San Francisco, 1600 Divisadero St., San Francisco, CA, 94115, USA. · Pubmed 28577080
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · University of California San Francisco School of Medicine, Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA. · Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA. · Pubmed 28503722
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco. · Biocon Research Limited, Bangalore, India3Now with Mylan Inc, Canonsburg, Pennsylvania. · Department of Haematology, Oncology, and Stem Cell Transplantation, University Medical Centre Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. · Quiron-Dexeus, Barcelona, Spain. · Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. · Mylan Inc, Canonsburg, Pennsylvania. · Biocon Research Limited, Bangalore, India. · City Clinical Oncology Dispensary, Saint Petersburg, Russia. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Regional Clinical Oncological Center, Kazan, Russia. · Institute of Clinical Oncology, Tbilisi, Georgia. · St Luke's Medical Center Global City, Taguig City, Philippines. · Cardinal Santos Medical Center, Manila, Philippines. · Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia. · Siriraj Hospital, Bangkok, Thailand. · Sumy State University, Sumy, Ukraine. · King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. · City Cancer Center, Vijayawada, India. · Curie Manavata Cancer Centre, Nasik, India. · Instituto Clinico Oncologico del Sur, Temuco, Chile. · Pubmed 27918780
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Samuel Merritt University, Oakland, California. · Pubmed 27832260
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 28949948
  • Executive Vice Chair, Surgery; Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA. · Professor of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA. · Vice President, Healthcare Outcomes and Policy, Roswell Park Cancer Institute, Buffalo, NY. · Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Medicine; Director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, San Francisco, CA. · Chairman, Department of Radiation Oncology, Albert Einstein Healthcare Network, Philadelphia, PA. · Professor of Pathology, University of Vermont, Burlington, VT. · Associate Director, Kellogg Cancer Surgical Services, NorthShore University HealthSystem, Evanston, IL. · Professor; Co-Director, Breast Cancer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28294295
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, 94115, USA. Electronic address: · Helsinn Healthcare SA, 6912, Pazzallo, Lugano, Switzerland. · IMO Clinique de Genolier, CH-1272, Genolier, Vaud, Switzerland. · Pubmed 28285236
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 29200414
2016
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. · Pubmed 27185850
  • School of Dental Medicine and Neag Comprehensive Cancer Center, UConn Health, Farmington, Connecticut. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, New York. · Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York. · School of Dentistry, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington. · New York University College of Dentistry, New York, New York. · Penn State Hershey Medical Center, Hershey, Pennsylvania. · Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California. · School of Dentistry and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. · Pubmed 27334013
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 26507507
  • Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. · Division of Hematology-Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26303211
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Box 1710, San Francisco, CA, 94115, USA. · Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc, Kenilworth, NJ, USA. · Merck Research Laboratories, North Wales, PA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Sanfrancisco, CA, USA. · Pubmed 26875185
  • Department of Cell and Tissue Biology, University of California, San Francisco (UCSF), San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. · Department of Surgery, University of California, San Francisco, San Francisco, California, USA. · Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA. · Department of Anatomy, University of California, San Francisco, San Francisco, California, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. · Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. · Department of Medicine, University of California, San Francisco, San Francisco, California, USA. · Pubmed 27775705
  • Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. · Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA. · Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. · Department of Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 27224917
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. Electronic address: · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 26874902
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27379943
2015
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • University of Alabama at Birmingham, Birmingham, Alabama. · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · University of Alabama at Birmingham, Birmingham, Alabama. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Georgetown University Hospital, Washington, District of Columbia. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The University of Chicago, Chicago, Illinois. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan-Kettering Cancer Center, New York, New York. · University of Michigan, Ann Arbor, Michigan. · Baylor College of Medicine, Houston, Texas. · University of North Carolina, Chapel Hill, North Carolina. · Mayo Clinic College of Medicine, Rochester, Minnesota. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · Pubmed 25779953
  • Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 26520840
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA, 94115, United States of America. · Siemens Healthcare Diagnostics, Elkhart, IN, 46516, United States of America. · Pubmed 26496203
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • University of Pennsylvania, Philadelphia, Pennsylvania. · University of Minnesota, Minneapolis, Minnesota. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Loyola University Medical Center, Maywood, Illinois. · Buck Institute for Research on Aging, Novato, California. · Mayo Clinic, Rochester, Minnesota. · University of California, San Francisco, San Francisco, California. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Oregon Health and Science University, Portland, Oregon. · Inova Fairfax Hospital Cancer Center, Fairfax, Virginia. · University of Colorado Denver, Denver, Colorado. · University of Alabama at Birmingham, Birmingham, Alabama. · University of Texas Southwestern, Dallas, Texas. · Georgetown University Medical Center, Washington, DC. · Swedish Cancer Institute, Seattle, Washington. · University of Washington, Seattle, Washington. · Emory University, Atlanta, Georgia. · H. Lee Moffitt Cancer Center, Tampa, Florida. · University of Chicago, Chicago, Illinois. · QuantumLeap Healthcare Collaborative, San Francisco, California. · University of California, San Diego, San Diego, California. · Gemini Group Ann Arbor, Michigan. · George Mason University, Fairfax County, Virginia. · University of Southern California, Los Angeles, California. · University of Arizona Cancer Center, Tucson, Arizona. · University of California, San Francisco, San Francisco, California. · Pubmed 25712686
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Baylor University College of Medicine, Houston, Texas. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Duke University Medical Center, Durham, North Carolina. · Georgetown University, Washington, District of Columbia. · Laura & Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25524311
  • Augmentium Pharma Consulting Inc, Toronto, Ontario, Canada. Electronic address: · Sylvester Comprehensive Care Center, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida. · Eisai Inc, Woodcliff Lake, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25433768
  • Division of Hematology-Oncology, University of California San Francisco, San Francisco, California. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 25351747
  • Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address: · Department of Radiation Medicine and Applied Sciences, University of California San Diego Moores Cancer Center, San Diego, CA. · Athena Breast Health Network, San Francisco, CA. · Department of Medicine (Hematology/Oncology), University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Department of Surgical Oncology, Duke University, Durham, NC. · Department of Surgical Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA. · Department of Radiation Oncology, University of California Irvine, Orange, CA. · Department of Radiation Oncology, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica, Santa Monica, CA. · Department of Radiation Oncology, University of California Helen Diller Comprehensive Cancer Center, San Francisco, CA. · Pubmed 25245425
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • From the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Pubmed 25006724
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA. · Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France. · Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. · Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. · Breast Cancer Centers, Memorial Cancer Institute, Hollywood. · Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium. · Sarah Cannon Research Institute, Nashville, USA. · Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada. · Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Ironwood Cancer & Research Centers, Chandler. · Novartis Pharmaceuticals Corporation, East Hanover. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 25231953
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 250 25th Avenue N, Ste 100 Nashville, TN 37203, USA. · Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. · University of Pittsburgh Cancer Institute, 200 Lothrop Street, Pittsburgh, PA 15213, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon, NH 03756, USA. · AdvancedBC.org 250 West 82 Street, #42, New York, NY 10024, USA. · Statistical Innovations Inc, 375 Concord Avenue, Belmont, MA 02478, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. · 1] EpiSource, LLC, 53 Fenwick Road, Waban, MA 02468, USA [2] Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA. · Pubmed 24743708
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. · Pubmed 24615500
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA · Institut Multidisciplinaire D'Oncologie, Genolier, Switzerland. · Pubmed 25085504
2013
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-0875, USA. · Pubmed 23649189
  • University of California San Francisco, San Francisco, California. · Pubmed 24892840
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 24637554
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143-1710, USA, · Pubmed 24062208
2012
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., 2nd Floor, Box 1710, B-608, San Francisco, CA 94143, USA. · Pubmed 22198412
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, USA. · Pubmed 22393793
2011
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Ave, Second Floor, Box 1710, San Francisco, CA 94115, USA. · Pubmed 21555686
  • UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, CA, USA. · Pubmed 22362269
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 22355830
2010
  • University of California, San Francisco, CA 94115 , USA. · Pubmed 20705561
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 94115, USA. · Pubmed 20051811
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2016
  • Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center; Barbara Fowble, University of California San Francisco, San Francisco; Rita S. Mehta, University of California Irvine, Orange, CA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA; Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH; Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI; Hannah Klein Connolly, Patient Representative, Edina, MN; Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex; Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom; James N. Ingle, Mayo Clinic, Rochester, MN; Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL; Larissa A. Korde, University of Washington, Seattle, WA; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA. · Pubmed 27217461
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California; Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.); U.S. Oncology Research, The Woodlands, TX (S.J.); Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); British Columbia Cancer Agency, Vancouver, Canada (K.G.); Brustzentrum der Universität München (LMU), Munich, Germany (N.H.); State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.); All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.); M.D. Anderson Cancer Center, University of Texas, Houston (S.M.); and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada; Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain; Thomas Bachelot, Centre Léon Bérard, Lyon, France; Shinzaburo Noguchi, Osaka University Medical School; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL; Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA; and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Department of Medicine, University of California, 1600 Divisadero St., Box 1710, San Francisco, CA, 94115, USA, · Pubmed 26208485
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
2014
  • Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25349301
  • A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, and Mark M. Moasser, Helen Diller Family Comprehensive Cancer Center; A. Jo Chien, Pamela N. Munster, Michelle E. Melisko, Hope S. Rugo, John W. Park, Andrei Goga, Glenna Auerback, Elham Khanafshar, Karen Ordovas, and Mark M. Moasser, University of California San Francisco, San Francisco, CA; and Kevin M. Koch, GlaxoSmithKline, Research Triangle Park, NC. · Pubmed 24711549
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • 1233 Arguello Blvd, San Francisco, CA 94122, USA. · Pubmed 24142513
2013
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisidero Street, Box 1710, San Francisco, CA 94143-1710, USA. · Pubmed 23143215
  • Authors' Affiliations: Breast Cancer Medicine Service, Departments of Pathology, Biostatistics, and Radiology, Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York; Dana-Farber Cancer Institute; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Rochester, Minnesota; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia; University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham, North Carolina; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California; University of Alabama at Birmingham, Birmingham, Alabama; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Pubmed 23965901
  • Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 23135909
2012
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 2nd floor, San Francisco, CA 94115, USA. · Pubmed 23148612
  • School of Medicine, University of California, San Francisco, 1106 Stanyan St., San Francisco, CA 94117, USA. · Pubmed 22798157
  • Department of Anatomy, University of California, San Francisco, CA 94143, USA. · Pubmed 22728437
  • Breast Care Center, University of California at San Francisco, 1600 Divisadero St, 2nd Floor, Box 1710, San Francisco, CA 94115, USA. · Pubmed 22649152
  • School of Nursing, University of California, San Francisco, California 94143-0610, USA. · Pubmed 22515947
  • Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 22207277
  • University of California San Francisco, 1600 Divisadero Street, Box 1710, San Francisco, CA 94115, USA. · Pubmed 22198468
  • Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 21825174
2011
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 22142661
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 21480257
  • Division of Hematology and Oncology, University of California, San Francisco, 1600 Divisadero, Rm A719 Box 1711, San Francisco, CA 94143, USA. · Pubmed 21559012
  • Department of Pathology, University of California, San Francisco, USA. · Pubmed 22039576
2010
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Pubmed 20805062
  • Department of Medicine, University of California San Francisco, 94115, USA. · Pubmed 20602189
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 20175700
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 20164688
2009
  • University of California San Francisco, San Francisco, CA, US. · Pubmed 19593514
  • University of California, San Francisco, CA, United States. · Pubmed 19850438
Washington University
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
2015
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Terry S. Langbaum, and Judith E. Karp, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Beverly Moy, Massachusetts General Hospital Cancer Center; Melissa E. Hughes and Jane C. Weeks, Dana-Farber Cancer Institute, Boston, MA; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Keith Stockerl-Goldstein, Siteman Cancer Center at Washington University School of Medicine, St Louis, MO; Leigh Neumayer, Huntsman Cancer Center at University of Utah School of Medicine, Salt Lake City, UT; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25534386
University of San Francisco
2016
  • From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of San Francisco School of Medicine, San Francisco, CA; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. · Pubmed 27249746
109 Other Locations Show
Yearly article counts 3191920191825161040